China's Economy, Geopolitical Risk, And Zero Covid Policies

WisdomTree profile picture


  • China’s political system is highly state-dominated but significantly less than it was 50 years ago.
  • Following the Russian invasion of Ukraine, Chinese companies have mostly complied with U.S. sanctions and bought Russian oil.
  • China’s official GDP number is highly smoothed and its investment measurements unreliable.
  • Chinese companies have proven to be more resilient than the market expected as the biggest impact of COVID Zero has been on small, service-oriented shops.

Multi exposure of virtual abstract financial graph interface on Chinese flag and sunset sky background, financial and trading concept

Igor Kutyaev/iStock via Getty Images

By Liqian Ren

China will be a headline in the U.S. for the coming decades, as its top strategic competitor. Let's detangle various aspects of this competition.

First, politics is the elephant in the room. China's political system is highly state-dominated but significantly less than it was 50 years ago when President Nixon visited. Understandably, many want to avoid investing in China for this reason alone.

We believe our non-state-owned strategy is still the best way to invest in any emerging market, not just China. If you are considering a benchmark Chinese equity allocation, the impact of politics and regulations on companies is unavoidable, in many ways similar to other emerging markets. But China will get more attention than most, just for the size of its economy.

I recently talked with Victor Shih and Dingding Chen on a recent episode of the China of Tomorrow podcast. Victor has a new book, Coalition of the Weak, that explains some of the patterns and logic behind Chinese politics. He made some predictions for the October party congress and explained the decline of the princelings in the Chinese communist party.

The two charts below illustrate that a majority of the Chinese equity market cap is now in non-state-owned companies, and a majority of Chinese citizens work in the non-state-owned part of the economy.

This presence of a deep market economy and state power is a unique phenomenon. China will be a formidable challenge for the U.S. If the U.S. understanding of China is just horror stories about state power, it may make people here feel good, but it won't help the U.S. compete.

State-Owned Company Market Cap Weight in MSCI China Index

State-Owned Company Market Cap Weight in MSCI China Index


China: % Urban Workers for Private Businesses

China: % Urban Workers for Private Businesses


Second, China has its unique set of geopolitical risks. Following the Russian invasion of Ukraine, Chinese companies have mostly complied with U.S. sanctions and bought Russian oil. Its behavior has been like India's, but as the main U.S. competitor, China's behaviors are reported more critically. This should be a baseline expectation going forward, as a side effect of being the world's second-largest economy.

Taiwan is another geopolitical risk. But I believe this risk is vastly exaggerated and exploited by the U.S., China, and Taiwan, for domestic audience consumption. It's a topic that unites the political base. China itself uses Taiwan to divert political attention away from domestic troubles. For now, President Xi's political power is secure enough that it doesn't need a preemptive war in Taiwan to shore up domestic support, making it a highly unlikely event.

The biggest geopolitical risk for China is how far and deep economic de-coupling with the U.S. will go. It's clear the U.S. wants to decouple, and to an extent it already has.

The more China is decoupled from the U.S. economy, the easier it is for the U.S. to impose economic sanctions. However, it is also costly for the U.S. to decouple from China as it needs to invest in its own economy, face lower productivity growth and higher inflation. Recently, President Biden loosened solar panel imports from South Asian countries and promised no new tariffs on Chinese products. It's no secret that the Chinese capital is behind many of those South Asian products. This decoupling process will be a long winding road and the outcome is uncertain.

Third, China's economy. There's disagreement about what China's potential growth rate is for the next decade. Some pessimistic analysts put it around 3% annually. Some, like Justin Yifu Lin, put it closer to 7%. China's central bank, PBOC, put it around 5%-6%. We still believe 4.5-5.5% is a good range for China's 5-10-year growth potential.

China's official GDP number is highly smoothed and its investment measurements unreliable. However, data like train and subway ridership, trucking traffic on national highways, daily congestion and many monthly and high-frequency daily data usually offer a good assessment of the actual economy. Import and export data are also highly reliable as they can be confirmed by data from trading countries. Year-to-date, the Chinese economy is still likely running positive, bolstered by significant growth in Q1 before the Shanghai Omicron wave.

China Monthly Electricity Usage (%y/y)

China Monthly Electricity Usage (%y/y)


One couldn't talk about China's economy within the next two years without touching on China's COVID Zero policy.

Several points about COVID Zero policies are ignored in the U.S. media. First, public support for COVID Zero was high, even after Shanghai, although that support is now lower. Second, public support for a vaccine mandate is not that high, which resulted in a low vaccination rate among the elderly. Third, it is politicized more this year, and the party and top leaders would prefer not to deal with headline death numbers.

Shanghai, even with the best medical resources in China, has about a 0.1% death rate. Thirty percent of Chinese infected would mean 420,000 deaths. Even if China uses more effective vaccines and magically achieves Singapore's 0.04% death rate, that's still 150,000 deaths, which is a headline President Xi does not want going into the most important political event of his era.

Thus, COVID Zero will continue and significantly constrain domestic consumption. The government will look and see how much China's economy bounces back in the next few months, then make decisions later.

However, I believe China's final goal is still to live with the virus, given the rest of the world has lived with the virus. In the last three months, foreign visitors' quarantine requirements have been lowered from 14 days to 10. We can expect that to change to seven soon. After Shanghai, the government finally got a sense of urgency in pushing for old age vaccinations, which should get to 90% or more for those aged 60 and up in the next three months. All these point to a slow but eventual re-opening.

Fourth, Chinese company earnings. The cold-hearted truth is the economy and company earnings are correlated, but not 100%. Main Street is not Wall Street, in the U.S. or in China. Chinese companies have proven to be more resilient than the market expected as the biggest impact of COVID Zero has been on small, service-oriented shops. It's also the case that going forward, Shanghai-style lockdowns will be less likely for the economically significant cities. They mostly had gotten COVID under control during the Shanghai wave without resorting to lockdowns.

As the DiDi (OTCPK:DIDIY) and BABA's experiences showed, individual Chinese companies face significant regulatory risk, which is why we strongly recommend clients limit exposure. It's also not healthy when Chinese equity performance is too driven by policy leaks and government speeches, even on the positive side. The more it's driven by sentiment and policy directives, the more we caution clients to be patient because many times, it is what's implemented that matters for company earnings.

Second-quarter company earnings are expected to be significantly lower as Shanghai and its surrounding Yangtze River Delta region are central to China's economy. But China's production bounce-back could also be swifter because its labor standards are more reflective of an emerging market country, which gives employers significant clout in ramping up production.



I recently talked with Dr. Peter Luo, founder, and CEO of ADAGENE (ADAG), a U.S.-listed Biotech firm headquartered in China, on earnings and COVID-related challenges. Medical research is an area where the U.S. and China will likely see both more competition and cooperation.

In summary, we continue to believe China is investable and the risk of the near-term Taiwan conflict is exaggerated. China's economy, though slower and extremely uncertain this year, can still grow at rates of 3.5%-5.5%. Private Chinese companies are still driven by the strong entrepreneurial will to succeed, and we believe that's still the most vital part of Chinese equity.

Liqian Ren, Director of Modern Alpha

Liqian Ren, Ph.D., joined WisdomTree as Director of Modern Alpha in 2018. She leads WisdomTree's quantitative investment capabilities and serves as a thought leader for WisdomTree's Modern Alpha® approach. Liqian was previously at Vanguard, where she worked for 12 years, most recently as a portfolio manager in the Quantitative Equity Group managing Vanguard's active funds and conducting research on factor strategies. Prior to joining Vanguard, she was an associate economist at the Federal Reserve Bank of Chicago. Liqian received her bachelor's degree in Computer Science from Peking University in Beijing, her master's in Economics from Indiana University-Purdue University Indianapolis, and her MBA and Ph.D. in Economics from the University of Chicago Booth School of Business. Liqian co-hosts a podcast on China and Asian markets with Jeremy Schwartz, WisdomTree's Global Head of Research, and she is a co-host on the Wharton Business Radio program Behind the Markets on SiriusXM 132.

Original Post

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors.

This article was written by

WisdomTree profile picture
WisdomTree launched its first ETFs in June of 2006, and is currently the industry's fifth largest ETF provider. The WisdomTree Seeking Alpha profile will feature content by some of our leading analysts including: Luciano Siracusano: Luciano Siracusano is WisdomTree's Chief Investment Strategist and Head of Sales. He is the co-creator with CEO Jonathan Steinberg of WisdomTree's patented Indexing methodology and has led the firm's sales force since 2008. Luciano is a regular guest on CNBC and FOX Business, and speaks frequently on ETFs, indexing and global financial markets. A former equity analyst at ValueLine, Luciano began his career as a speechwriter for former New York Governor Mario Cuomo and HUD Secretary Henry Cisneros. He graduated from Columbia University with a B.A. in Political Science in 1987. Jeremy Schwartz: As WisdomTree’s Director of Research, Jeremy Schwartz offers timely ideas and timeless wisdom on a bi-monthly basis. Prior to joining WisdomTree, Jeremy was Professor Jeremy Siegel's head research assistant and helped with the research and writing of Stocks for the Long Run and The Future for Investors. He is also the co-author of the Financial Analysts Journal paper “What Happened to the Original Stocks in the S&P 500?” and the Wall Street Journal article “The Great American Bond Bubble.” Christopher Gannatti: Christopher Gannatti began at WisdomTree as a Research Analyst in December 2010, working directly with Jeremy Schwartz, CFA®, Director of Research. He is involved in creating and communicating WisdomTree’s thoughts on the markets, as well as analyzing existing strategies and developing new approaches. Christopher came to WisdomTree from Lord Abbett, where he worked for four and a half years as a Regional Consultant. Rick Harper: Rick Harper serves as the Head of Fixed Income and Currency for WisdomTree Asset Management, where he oversees fixed income and currency products developed through our collaborations with the BNY Mellon Corporation and Western Asset Management. Rick has over 19 years investment experience in strategy and portfolio management positions at prominent investment firms. Prior to joining WisdomTree in 2007, Rick held senior level strategist roles with RBC Dain Rauscher, Bank One Capital Markets, ETF Advisors, and Nuveen Investments. Bradley Krom: Bradley Krom joined WisdomTree as a member of the Fixed Income and Currency team in December 2010. He is involved in creating and communicating WisdomTree’s thoughts on currency and fixed income markets, as well as analyzing existing and new fund strategies. Prior to joining WisdomTree, Bradley served as a senior trader on a proprietary trading desk at TransMarket Group. Tripp Zimmerman, Research Analyst Tripp Zimmerman began at WisdomTree as a Research Analyst in February 2013. He is involved in creating and communicating WisdomTree’s thoughts on the markets, as well as analyzing existing strategies and developing new approaches. Prior to joining WisdomTree, Tripp worked for TD Ameritrade as a fixed income specialist. Tripp also worked for Wells Fargo Advisors, TIAA-CREF and Evergreen Investments in various investment related roles. Tripp graduated from The University of North Carolina at Chapel Hill with a dual degree in Economics and Philosophy. Tripp is a holder of the Chartered Financial Analyst designation. Jonathan Steinberg, CEO Prior to establishing WisdomTree, Jonathan founded, and served as Chairman and CEO of Individual Investor Group, Inc. From 1998 to 2004, he held the role of Editor-in-Chief of Individual Investor and Ticker magazines. Before his entrepreneurial accomplishments, Jonathan was an Analyst in the Mergers & Acquisitions division at Bear Stearns & Co. He attended The Wharton School at the University of Pennsylvania and is the author of Midas Investing, published by Random House in 1996. Zach Hascoe, Capital Markets Zach Hascoe began at WisdomTree in August 2010, and works directly with David Abner, Head of Capital Markets. The Capital Markets group is involved in all aspects of the WisdomTree ETFs including product development, helping to seed and bring new products to market, as well as trading strategies and best execution strategies for the client base. Zach works closely with the trading and liquidity community and does analytics on ETF baskets and the capital markets. He is a frequent contributor to the WisdomTree blog on topics related to the capital markets, liquidity, structure and best execution. In addition, he manages the hedge fund relationships for the firm. Zach received a B.A. from Bucknell University and was Captain of the Bucknell Tennis Team.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.